Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chemotherapy effects on coagulation in advanced pancreatic cancer
NL-OMON41433Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2014
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label trial of ccx872-b, fluorouracil, irinotecan and oxaliplatin in pancreatic cancer (PC) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Increase of procoagulant microparticles during chemotherapy and Source of procoagulant microparticles. Started Jan 2014; status: active, not recruiting.
02
Drugs
ccx872-bfluorouracilirinotecanoxaliplatin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NL-OMON41433.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41433.